RCP Diagnostics LLC

The principal goal of RCP Diagnostics is to commercialize a blood-based diagnostic for estrogen-associated cancers in women. The assay, initially developed as a radioimmunoassay, detects the presence of a protein that ferries vitamin B-2, or riboflavin, throughout the body.

2400 East Arizona Biltmore Circle

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight